Eurasia reports: research on the return on investment in ACT-A to 10 countries
3 December 2020
| Publication
Overview
Eurasia Group analysis shows that an equitable COVID-19 vaccine solution would generate at least US$153 billion of economic benefits in 2020-21 for ten of the world's largest donor countries. This provides further and independent evidence to support the compelling case to invest in the ACT-Accelerator.
Click download for the summary analysis or use the links to view the donor country reports:
WHO Team
ACT Accelerator
Number of pages
10